HAWTHORNE, N.Y.--(BUSINESS WIRE)--March 13, 2006--Acorda Therapeutics (Nasdaq: ACOR) today announced that the underwriters of its initial public offering have exercised a portion of their over-allotment option to purchase an additional 575,614 shares of common stock at the public offering price of $6.00 per share. The exercise of the over-allotment option increases the size of the initial public offering to 6,075,614 shares of common stock.
